Literature DB >> 24619886

Glucose impairment and ghrelin gene variants are associated to cognitive dysfunction.

M Mora1, M L Mansego, M Serra-Prat, E Palomera, X Boquet, J F Chaves, M Puig-Domingo.   

Abstract

BACKGROUND AND AIMS: Cognitive state and brain volume have been related to body mass index, abdominal fat, waist-hip ratio, components of metabolic syndrome (MS) and ghrelin. Genetic variations within the ghrelin gene have been recently associated to MS. The aim of our study was to investigate cognitive state by Mini-Mental State Examination (MMSE) in relation to MS components (ATP-III criteria) and ghrelin gene polymorphisms in dwelling individuals aged ≥70.
METHODS: 280 subjects (137 men/143 women, age 77.03 ± 5.92) from the Mataró Ageing Study were included. Individuals were phenotypically characterized by anthropometric variables, lipids, glucose, blood pressure and MMSE. SNPs -501AC (rs26802), -994CT (rs26312), -604GA (rs27647), M72L (rs696217) and L90G (rs4684677) of the ghrelin gene were studied. Genotypes were determined by polymerase chain reaction and SNapshot minisequencing.
RESULTS: 22.1 % had MMSE <24. MMSE <24 was associated with age (p < 0.001), female gender (p = 0.016), low education (p < 0.001) and glucose impairment or diabetes (p = 0.040). MMSE was influenced by obesity, central obesity, MS and glucose impairment. This latter association remained significant after adjustment by gender, age, alcohol, educational level, GDS and ApoE genotype (p = 0.009). Ghrelin SNPs were associated to MMSE: M72L C/A genotype showed lower score than C/C (p = 0.032, after adjusting for confounders 0.049); L90G A/T genotype showed lower score than A/A (p = 0.054, after adjusting 0.005). MMSE <24 was associated to L90G (39.1 % in A/T genotype vs 19.3 % in A/A, p = 0.026, after adjusting for confounders p = 0.002, OR 6.18 CI 1.93-21.75).
CONCLUSIONS: Glucose impairment and L90G Ghrelin gene variant influence cognitive function in old dwelling individuals participating in the Mataró Ageing Study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24619886     DOI: 10.1007/s40520-014-0203-5

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

1.  Ghrelin Gene Variants Influence on Metabolic Syndrome Components in Aged Spanish Population.

Authors:  Mireia Mora; Victoria Adam; Elisabet Palomera; Sebastian Blesa; Gonzalo Díaz; Xavier Buquet; Mateu Serra-Prat; Juan Carlos Martín-Escudero; Ana Palanca; Javier Felipe Chaves; Manuel Puig-Domingo
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 2.  Therapeutic Potential of Targeting the Ghrelin Pathway.

Authors:  Gustav Colldén; Matthias H Tschöp; Timo D Müller
Journal:  Int J Mol Sci       Date:  2017-04-11       Impact factor: 5.923

3.  Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients.

Authors:  Rong Huang; Jing Han; Sai Tian; Rongrong Cai; Jie Sun; Yanjue Shen; Shaohua Wang
Journal:  Oncotarget       Date:  2017-02-28

4.  The Interaction Effect between Blood Stasis Constitution and Atherosclerotic Factors on Cognitive Impairment in Elderly People.

Authors:  Zhizhen Liu; Hongqing Yang; Mozhu Zhang; Jing Cai; Zijie Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-11       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.